市場調查報告書
商品編碼
1308169
血糖試紙市場:2023-2028年全球行業趨勢、佔有率、規模、成長、機會及預測Blood Glucose Test Strips Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028 |
2022年,全球血糖試紙市場規模達到116億美元。展望未來,IMARC Group預計到2028年,該市場規模將達到189億美元,2023-2028年期間的年複合成長率(CAGR)為8.2%。
血糖試紙是指用於監測血糖水準和控製糖尿病症狀的小型 拋棄式塑膠或紙質試紙。血糖試紙由聚烯烴、聚醯胺、聚碸和纖維素材料製成。血糖試紙由多種成分組成,如親水性、粘合劑、感測器、酶和電極層。它們還浸泡在葡萄糖氧化酶中,葡萄糖氧化酶與血樣中的葡萄糖發生反應,從而顯示血糖水準。除此之外,血糖試紙使用方便,成本效益高,可每天使用。因此,血糖試紙有助於識別高血糖或低血糖水準,監測糖尿病治療效果,降低發生低血糖和/或高血糖的風險。
糖尿病發病率不斷上升,尤其是在不斷成長的老年人口中,這為市場帶來了積極的前景。因此,血糖試紙被廣泛用於在家中定期檢測血糖水準,而無需前往診斷實驗室,這為市場成長提供了支持。此外,由於血糖儀易於獲得、操作方便、準確度高,產品在2型糖尿病患者中的廣泛應用也有利於市場成長。此外,在冠狀病毒病(COVID-19)大流行期間,血糖監測設備和試紙等耗材的需求和線上銷售大幅增加。這可歸因於作為預防措施和記錄感染後症狀,患者和普通人對持續監測血糖水準的需求不斷增加,這反過來又促進了市場成長。其他因素,包括生物醫學工程領域廣泛的研發活動、不斷變化的生活方式和飲食習慣,以及政府實施的各種以教育大眾了解糖尿病及其預防措施為重點的計劃,預計將推動市場成長。
The global blood glucose test strips market size reached US$ 11.6 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 18.9 Billion by 2028, exhibiting a growth rate (CAGR) of 8.2% during 2023-2028.
Blood glucose test strips refer to small, disposable plastic or paper strips used to monitor blood glucose levels and control diabetes symptoms. They are manufactured using polyolefin, polyamide, polysulfone and cellulose materials. A blood glucose test strip comprises several components, such as hydrophilic, adhesive, sensors, enzymes and electrode layers. They are also soaked in glucose oxidase that reacts with glucose present in the blood sample to indicate sugar levels. Apart from this, blood glucose test strips are easy to use, cost-effective, and can be used daily. Consequently, they assist in identifying high or low blood sugar levels, monitoring the effectiveness of diabetes treatment, and lowering the risks of developing hypoglycemia and/or hyperglycemia.
The increasing prevalence of diabetes, especially among the growing geriatric population is creating a positive outlook for the market. In line with this, blood glucose test strips are widely used to test sugar levels regularly at home, while eliminating the need to visit a diagnostic laboratory, which is supporting the market growth. Additionally, the widespread product adoption among type-2 diabetic patients due to the easy availability of glucometers, convenient handling, and the level of accuracy provided by the machine are favoring the market growth. Moreover, the demand and online sales for blood glucose monitoring devices and consumables, such as test strips significantly surged during the coronavirus disease (COVID-19) pandemic. This can be attributed to the increasing need to continuously monitor sugar levels in patients and commoners both as a precautionary measure and to record post-infection symptoms, which, in turn, is augmenting the market growth. Other factors, including extensive research and development (R&D) activities in the field of biomedical engineering, evolving lifestyles and eating habits, and the implementation of various government initiatives focusing on educating the masses regarding diabetes and its preventive measures, are anticipated to drive the market toward growth.
IMARC Group provides an analysis of the key trends in each sub-segment of the global blood glucose test strips market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on type, technology, distribution channel and end user.
Thick Film Electrochemical Films
Thin Film Electrochemical Films
Optical Strips
Glucose Dehydrogenase (GDH)
Glucose Oxidase (GOD)
Online
Offline
Individuals
Hospitals and Clinics
Others
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The competitive landscape of the industry has also been examined along with the profiles of the key players being 77 Elektronika Kft., Abbott Laboratories, AgaMatrix Inc., Ascensia Diabetes Care Holdings AG (PHC Holdings), B. Braun Melsungen Aktiengesellschaft, Bioland Technology Ltd., Bionime Corporation, BTNX Inc., Microlife Corporation (Midas Company Limited), Norditalia Group S.R.L., Rossmax International Ltd. and Unistrip Technologies LLC.